Martin A. Lehr - 09 Jun 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CNTX
Reported as of: 09 Jun 2025
Net transaction value: +$70,080
SEC form: 4
Accepted by SEC: 10 Jun 2025, 17:26:21 UTC
Prior SEC filing: 14 Feb 2025
Next SEC filing: 23 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Alex Levit, Attorney-in-Fact

Key filing fact

Martin A. Lehr filed Form 4 for Context Therapeutics Inc. (CNTX) on 10 Jun 2025.

Key facts

This page summarizes Martin A. Lehr's Form 4 filing for Context Therapeutics Inc. (CNTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jun 2025, 17:26.

Change

Previous filing in this sequence was filed on 14 Feb 2025.
Current net transaction value: +$70,080.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001861989 Primary reporting owner

Lehr Martin A.

Relationship: Chief Executive Officer, Director
Address: 2001 MARKET STREET, SUITE 3915, UNIT #15, PHILADELPHIA
Signature: /s/ Alex Levit, Attorney-in-Fact
Signature date: 10 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNTX transaction

Common Stock

Purchase

Transaction value: $70,080
Shares: +100,000
Change %: +12%
Price: $0.7008
Shares after: 920,190
Date: 09 Jun 2025
Ownership: Martin Lehr 2000 Trust
Footnotes: F1

CNTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 159,701
Date: 09 Jun 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.